期刊文献+

微透析技术在肿瘤中的应用

Application of microdialysis in tumor
原文传递
导出
摘要 微透析技术是一种定向深入靶组织的自动生物取样技术。它可从分子水平上监测肿瘤病理生理学改变引起的靶组织药物及相关物质变化,用于评价肿瘤靶组织药物的药代动力学,优化联合用药,探究肿瘤的分子靶向治疗及进行肿瘤的早期诊断和预后,为肿瘤防治研究提供新的思路和方法。 Microdialysis is an automatic biological sampling technique that is directed into the target tissue. Microdialysis is used to monitor the changes of drug and related substances associated with pathological physiology of tumor in the target tissue at the molecular level. Microdialysis is applied to evaluate the pharmaco-kinetics of drugs in the target tissue of tumor,optimize the combination therapy,explore molecular targeted therapy and study the early diagnosis and prognosis of tumor. Microdialysis provides a new idea and method for the prevention and cure research of tumor.
出处 《国际肿瘤学杂志》 CAS 2014年第8期570-573,共4页 Journal of International Oncology
基金 国家自然科学基金(81301662);中国博士后科学基金
关键词 微透析 肿瘤 药代动力学 诊断 预后 分子靶向治疗 Microdialysis Neoplasms Pharmacokinetics Diagnosis Prognosis Molecular targeted therapy
  • 相关文献

参考文献26

  • 1Jacobs S, McCully CL, Murphy RF, et al. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates[J].Cancer Chemother Pharmacol.2010, 65(5):817-824. 被引量:1
  • 2Dave N, Gudelsky GA, Desai PB. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis[J].Cancer Chemother Pharmacol.2013, 72(2):349-357. 被引量:1
  • 3Miyajima M, Kusuhara H, Takahashi K, et al. Investigation of the effect of active efflux at the bloodbrain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system[J].J Pharm Sci.2013, 102(9):3309-3319. 被引量:1
  • 4Blakeley JO, Olson J, Grossman SA, et al. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study[J].J Neurooncol.2009, 91(1):51-58. 被引量:1
  • 5Villarroel MC, Pratz KW, Xu L, et al. Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients[J].Invest New Drugs.2012, 30(6):2096-2102. 被引量:1
  • 6Martins FC, de Oliveira CF. Chemotherapy and the future: microdialysis as a local administration technique[J]. Eur J Gynaecol Oncol, 2009, 30(1): 5-8. 被引量:1
  • 7Martins FC, Santos JL, de Oliveira CF. Microdialysis: improving local chemotherapy in cancer using a mathematical model[J]. Front Biosci (Elite Ed), 2012, 4: 401-409. 被引量:1
  • 8Portnow J, Badie B, Chen M, et al. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation[J].Clin Cancer Res.2009, 15(22):7092-7098. 被引量:1
  • 9Konings IR, Sleijfer S, Mathijssen RH, et al. Increasing tumoral 5fluorouracil concentrations during a 5day continuous infusion: a microdialysis study[J].Cancer Chemother Pharmacol.2011, 67(5):1055-1062. 被引量:1
  • 10Redman LM, Moro C, Dobak J, et al. Association of β2 adrenergic agonist and corticosteroid injection in the treatment of lipomas[J].Diabetes Obes Metab.2011, 13(6):517-522. 被引量:1

二级参考文献16

  • 1Femkede S,Annuska G,Emiel R,et al.Gene expression profiling:Decoding breast cancer.Surg Oncol,2009,18(4):366-378. 被引量:1
  • 2Weigelt B,Hu Z,He X,et al.Molecular portraits and 70-gene prognosis signature are preserved throughout the Meta static process of breast cancer.Cancer Res,2005,65(20):9155-9158. 被引量:1
  • 3Cardoso F,Van't Veer L,Rutgers E,et al.Clinical application of the 70-gene profile:the MINDACT trial.J Clin Oncol,2008,26(5):729-735. 被引量:1
  • 4Paik S,Shak S,Tang G,et al.A multigene assay to predict recurrence of tamoxifen-treated,node-negative breast cancer.N Engl J Med,2004,351 (27):2817-2826. 被引量:1
  • 5Fiets WE,Nortier JW.A multigene RT-PCR assay used to predict recurrence in early breast cancer:two presentations with contradictory results.Breast Cancer Res,2004,6(5):185-187. 被引量:1
  • 6Habel LA,Shak S,Jacobs MK,et al.A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.Breast Cancer Res,2006,8(3):R25. 被引量:1
  • 7Wirapati P,Sotiriou C,Kunkel S.Meta-analysis of gene expression profiles in breast cancer:toward a unified understanding of breast cancer subtyping and prognosis signatures.Breast Cancer Res,2008,10(4):R65. 被引量:1
  • 8Desmedt C,Ruiz-Garcia E,André F.Gene expression predictors in breast cancer:current status,limitations and perspectives.Eur J Cancer,2008,44(18):2714-2720. 被引量:1
  • 9Sotiriou C,Piccart MJ.Taking gene-expression profiling to the clinic:when will molecular signatures become relevant to patient care?.Nat Rev Cancer,2007,7(7):545-553. 被引量:1
  • 10Belluco C,Petricoin EF,Mammano E,et al.Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.Ann Surg Oncol,2007,14(9):2470-2476. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部